Mark Fridlyand - Director, Strategy & Corporate Development

Por um escritor misterioso
Last updated 24 janeiro 2025
Mark Fridlyand - Director, Strategy & Corporate Development
Mark Fridlyand - Director, Strategy & Corporate Development
Network quantification of EGFR signaling unveils potential for targeted combination therapy
Mark Fridlyand - Director, Strategy & Corporate Development
img_003.jpg
Mark Fridlyand - Director, Strategy & Corporate Development
Combustion, Chemistry, and Carbon Neutrality
Mark Fridlyand - Director, Strategy & Corporate Development
Edward Shenderovich - Co-founder & CEO at Synonym Biotechnologies
Mark Fridlyand - Director, Strategy & Corporate Development
Frontiers Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor
Mark Fridlyand - Director, Strategy & Corporate Development
Team:Moscow/Attributions
Mark Fridlyand - Director, Strategy & Corporate Development
CONFERENCE OF THE ASSOCIATION FOR JEWISH STUDIES
Mark Fridlyand - Director, Strategy & Corporate Development
SYNONYM Overview SignalHire Company Profile
Mark Fridlyand - Director, Strategy & Corporate Development
Bayesian metamodeling of complex biological systems across varying representations
Mark Fridlyand - Director, Strategy & Corporate Development
Applied Biclustering Methods For Big and High Dimensional Data Using R, PDF, Statistics
Mark Fridlyand - Director, Strategy & Corporate Development
VisRuler: Visual analytics for extracting decision rules from bagged and boosted decision trees - Angelos Chatzimparmpas, Rafael M. Martins, Andreas Kerren, 2023
Mark Fridlyand - Director, Strategy & Corporate Development
Phillip PRICE, Consultant, Doctor of Philosophy

© 2014-2025 atsrb.gos.pk. All rights reserved.